Tania Jain, MBBS
I am a physician scientist in the hematological malignancies and stem cell transplantation division with Sidney Kimmel Comprehensive Cancer Center at the Johns Hopkins and my academic focus is cellular therapy and transplantation in the treatment of high-risk hematological malignancies especially myeloproliferative neoplasms. My primary research focus is to develop strategies to improve outcomes and prevent relapse of hematological malignancies following allogeneic stem cell transplantation. I also serve as the director of the adult CAR T program for hematological malignancies as we grow our CAR T program to help patients with advanced hematological malignancies. My academic interest in this space lies in studying the aspects of toxicity of CAR T cell therapy with an aim to improve long term outcomes in these patients.
Attribution:SelfType of financial relationship:OtherIneligible company:Care Dx, Bristol Myers Squibb, Incyte, Abbvie, CTI, and KiteTopic:Advisory board participationDate added:07/19/2022Relationship end date:07/19/2022
Attribution:SelfType of financial relationship:OtherIneligible company:CTI Biopharma, SyneosHealth, IncyteTopic:Insitutional research supportDate added:07/19/2022Relationship end date:07/31/2024